8QH8
Human Carbonic Anhydrase II in complex with Lasamide (2,4-Dichloro 5-sulfamoyl benzoic acid)
Summary for 8QH8
| Entry DOI | 10.2210/pdb8qh8/pdb |
| Descriptor | Carbonic anhydrase 2, ZINC ION, 2,4-dichloro-5-sulfamoylbenzoic acid, ... (4 entities in total) |
| Functional Keywords | metalloenzyme, lyase, inhibitor |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 29624.56 |
| Authors | Baroni, C.,Ferraroni, M.,Carta, F. (deposition date: 2023-09-06, release date: 2024-09-18, Last modification date: 2025-10-01) |
| Primary citation | Baroni, C.,D'Agostino, I.,Renzi, G.,Kilbile, J.T.,Tamboli, Y.,Ferraroni, M.,Carradori, S.,Capasso, C.,Carta, F.,Supuran, C.T. Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies. Acs Med.Chem.Lett., 15:1749-1755, 2024 Cited by PubMed Abstract: Lasamide is a synthetic precursor and a contaminant of the diuretic Furosemide manufacturing process and represents a highly valuable building block for fragment-based drug discovery approaches. We assessed the ability of Lasamide to inhibit in vitro the human-expressed Carbonic Anhydrases by means of the stopped-flow technique, and we assessed its binding modes within hCAs II and XII-mimic catalytic clefts by X-ray crystallography. Interestingly, an unprecedented crystal form for the hCA IX mimic H-tag is reported and discussed herein. PubMed: 39411526DOI: 10.1021/acsmedchemlett.4c00341 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.04 Å) |
Structure validation
Download full validation report






